Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+0.4%
5Y CAGR+9.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+0.4%/yr
vs +11.8%/yr prior
5Y CAGR
+9.6%/yr
Recent deceleration
Acceleration
-11.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.77M | -20.0% |
| 2024 | $28.48M | +62.7% |
| 2023 | $17.50M | -22.3% |
| 2022 | $22.53M | +31.2% |
| 2021 | $17.17M | +19.3% |
| 2020 | $14.39M | -48.3% |
| 2019 | $27.84M | +93.0% |
| 2018 | $14.43M | -0.7% |
| 2017 | $14.53M | -32.9% |
| 2016 | $21.64M | - |